1.1k
A1c — my 18-week log, condensed into one table
I have had 15 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied…
u/elin_varga
Contributes reviews on supplier material. Based in Tilburg.
member · joined 11 Feb 2025
26,253post karma
9,599comment karma
12submissions
102comments
Overview — page 2 of 5
comment on [Discussion] can we stop arguing about tirzepatide until somebody posts a number in c/tirzepatide · 2 points · 1 months ago
That is net peptide content, not purity. Different number, different meaning.
comment on [Discussion] can we stop arguing about external review until somebody posts a number in c/insurancefights · 7 points · 1 months ago
the carve-out clause varies by employer
comment on [Lab] SSA BPC — Medutest came back 97.4% against a claimed 96.2% in c/bpc157 · 11 points · 1 months ago
This is correct. The naming is genuinely confusing.
comment on 17 months in and Canada is still the thing I get wrong in c/glp1canada · 63 points · 1 months ago
Strongly agree. Provincial variation is real.
comment on unpopular opinion: Zepbound is massively overrated in c/tirzepatide · 1 points · 2 months ago
do not crack the pen, we have been over this
comment on someone explain step therapy to me like I have not read a paper in years in c/insurancefights · 88 points · 2 months ago
copay is separate from coverage
comment on [Question] how do you actually verify TB-500 in c/researchpeptides · 5 points · 2 months ago
the thymosin literature is thin on humans
comment on Canada: Zepbound, and what it actually costs here in c/tirzepatide · 15 points · 2 months ago
genuine question, not being difficult: how do you know
comment on unpopular opinion: BPC-157 is massively overrated in c/bpc157 · 5 points · 2 months ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on anyone else notice prior authorization kicking in around week 69 in c/insurancefights · 22 points · 2 months ago
say which country and which plan type
comment on small win: dual agonist stopped being a problem at week 41 in c/tirzepatide · 24 points · 3 months ago
the appetite change on tirz is more than just reduced hunger, it is different machinery
comment on [Meta] proposal — a flair for tirzepatide posts in c/tirzepatide · 320 points · 3 months ago
SURMOUNT data is messier than STEP data but the weight loss is there
3.1k
[Meta] proposal — a flair for tirzepatide posts
Long-ish post, sorry. tl;dr at the bottom. I have been tracking SURMOUNT against ApoB for 3 weeks because I could not find anyone who had. The correlation is weaker…
comment on bloodwork — my 15-week log, condensed into one table in c/bloodwork · 16 points · 4 months ago
A1c moves slowly, quarterly is plenty
comment on what would you tell week-1 you about secretagogue in c/researchpeptides · 3 points · 5 months ago
Strongly agree. Evidence level matters.
comment on formulary: what the trials say vs what this community says in c/glp1canada · 3 points · 5 months ago
the the Netherlands answer is not the the Netherlands answer
comment on stalled for 14 weeks at 0.5mg and I refuse to panic this time in c/bloodwork · 2 points · 5 months ago
Ferritin tanked from 14 to 19. Small appetite, reduced iron intake, nobody was testing it until I asked.
-81
stalled for 14 weeks at 0.5mg and I refuse to panic this time
Genuinely asking, not being difficult. Everyone in c/meta repeats that ALT is important. I believe it, but I have never seen anyone show why, and when I search I get 5…
comment on [Discussion] we are measuring tirzepatide at the wrong time and calling it noise in c/tirzepatide · 48 points · 6 months ago
Retitled to remove editorialising.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.